SCHEMBL7716494

SCHEMBL7716494

C=C1/C(=C/C=C2\CCC[C@]3(C)[C@@H]([C@H](C)/C=C/C(=O)C4(C(=O)O)CC4)CC[C@@H]23)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 11/20 0.47
▸ ADRA1A P35348 2/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ PGR P06401 1/20 0.46
▸ HTR1A P08908 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A4 P31645 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ CYP24A1 Q07973 1/20 0.44
▸ LMNA P02545 2/20 0.43
▸ AR P10275 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ ABCB11 O95342 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8527095 1.00 VDR (0.47) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8995605 0.93 VDR (0.46) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL7718610 0.93 VDR (0.46) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8995650 0.91 VDR (0.48) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8705616 0.91 VDR (0.46) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8527098 0.91 VDR (0.46) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8188845 0.91 VDR (0.46) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL6060184 0.90 VDR (0.49) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8405524 0.90 VDR (0.50) VDRADRA1ANR1I2PGRHTR1A
SCHEMBL8076375 0.90 VDR (0.50) VDRADRA1ANR1I2PGRHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376480-B1 TREATMENT OF IMMUNE SYSTEM DISORDERS, OSTEOPOROSIS, ALOPECIA SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-23 — — US disclosed
US-6372731-B1 TREATMENT OF CELL PROLIFERATION AND BONE DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-16 — — US disclosed
EP-0832063-B1 VITAMIN D DERIVATIVES WITH C-25 SUBSTITUENTS, PROCESS FOR THEIR PREPARATION, INTERMEDIATE PRODUCTS AND THEIR USE IN PREPARING MEDICAMENTS SCHERING AG (DE) 2000-02-23 — — EP disclosed
US-5583125-A SKIN DISORDERS, ANTITUMOR AGENTS, AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 1996-12-10 — — US disclosed
Send feedback